Literature DB >> 11829121

Uptake of lamivudine by rat renal brush border membrane vesicles.

Takatoshi Takubo1, Toshihiro Kato, Junji Kinami, Kazuhiko Hanada, Hiroyasu Ogata.   

Abstract

Uptake of lamivudine, a nucleoside analogue antiviral agent, by brush border membrane vesicles (BBMV) prepared from rat renal cortex was investigated. Initial uptake of lamivudine by BBMV was stimulated in the presence of an outward pH gradient. Determination of the kinetic parameters of the initial uptake yielded apparent Km and Vmax values of 2.28 mm and 1.56 nmol (mg protein)(-1) (20 s)(-1), respectively. The pH-driven uptake of lamivudine was inhibited by organic cations such as trimethoprim and cimetidine. The inhibitory effect of trimethoprim on lamivudine uptake was competitive, with an apparent Ki of 27.6 microM. The uptake of lamivudine was also inhibited by nitrobenzylthioinosine, a representative inhibitor of nucleoside transport, and by other nucleoside analogues, such as azidothymidine and dideoxycytidine, that are excreted by renal tubular secretion. These findings suggest that efflux of lamivudine at the brush border membrane of renal tubular epithelium is mediated by an H+/lamivudine antiport system, which may correspond to the H+/organic cation antiport system, and that this system is also involved in the renal secretion of other nucleoside analogues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829121     DOI: 10.1211/0022357021771814

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Renal secretion of the antiviral nucleoside analog AM188 is inhibited by probenecid, p-aminohippuric acid, and cimetidine in the isolated perfused rat kidney.

Authors:  Jiping Wang; Roger L Nation; Allan M Evans; Susan Cox
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

2.  The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine.

Authors:  Ho-Sook Kim; Yu Eun Sunwoo; Ji Young Ryu; Ho-Jin Kang; Hye-Eun Jung; Im-Sook Song; Eun-Young Kim; Joo-Cheol Shim; Ji-Hong Shon; Jae-Gook Shin
Journal:  Br J Clin Pharmacol       Date:  2007-05-17       Impact factor: 4.335

3.  Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).

Authors:  Martina Ceckova; Josef Reznicek; Birgit Deutsch; Martin F Fromm; Frantisek Staud
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.